Pharmacotherapy for Post-traumatic stress disorder in combat veterans: Focus on antidepressants and atypical antipsychotic agents

P and T

Volumn 37, Issue 1, 2012, Pages 32-38

  Alexander, Walter ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; FLUOXETINE; FLUPHENAZINE; OLANZAPINE; PAROXETINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ALCOHOLISM; ARTICLE; ASTHENIA; BEHAVIOR DISORDER; BIPOLAR DISORDER; BIPOLAR I DISORDER; BULIMIA; CIVIL DEFENSE; DECREASED APPETITE; DEPRESSION; DIARRHEA; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG WITHDRAWAL; EJACULATION DISORDER; FATIGUE; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERSALIVATION; IMPOTENCE; INSOMNIA; MAJOR DEPRESSION; NAUSEA; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; SCHIZOPHRENIA; SIDE EFFECT; SLEEP DISORDER; SOCIAL PHOBIA; SOMNOLENCE; SUICIDAL BEHAVIOR; VETERAN; WEIGHT GAIN;

EID: 84856059628     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. The Management of Post-Traumatic Stress Working Group. VA/DoD Clinical Practice Guideline: Management of Post-traumatic Stress. Washington, D.C.: Department of Veterans Affairs and Department of Defense, October 2010. Available at: www.healthquality.va.gov/PTSD-FULL-2010c.pdf. Accessed June 5, 2011.
2. Jeffereys M. Clinician's guide to medications for PTSD. September 12, 2011. Available at: www.ptsd.va.gov/professional/pages/clinicians-guide-to-medications-for-ptsd.asp. Accessed October 20, 2011.
3. Zoloft® (sertraline HCl) Tablets and Oral Concentrate, prescribing information. New York: Roerig/Pfizer; September 2011. Available at: http://labeling.pfizer.com/ShowLabeling.aspx?id=517. Accessed October 17, 2011.
4. Paxil® (paroxetine HCl) Tablets and Oral Suspension, prescribing information. Research Triangle Park, N.C.: GlaxoSmith Kline; July 2011. Available at: http://us.gsk.com/products/assets/us_paxil.pdf. Accessed October 17, 2011.
5. Pexeva® (paroxetine mesylate) Tablets, prescribing information. Miami, Fla.: Nova Therapeutics, LLC; April 2011. Available at: www.pexeva.com/pdf/pi_pexeva.pdf. Accessed October 17, 2011.
6. Berger W, Mendlowicz MV, Marques-Portella C, et al. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:169-180.
7. Ballenger JC. Remission rates in patients with anxiety disorders treated with paroxetine. J Clin Psychiatry 2004;65:1696-1707.
8. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebocontrolled, flexible-dosage trial. J Clin Psychiatry 2001;62:860-868.
9. Hertzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: A placebo-controlled trial in combat veterans. Ann Clin Psychiatry 2000;12:101-105.
10. Prozac® (fluoxetine HCl) Parvules for Oral Use, prescribing information. Indianapolis, Ind.: Eli Lilly; June 2011. Available at: http://pi.lilly.com/prozac.pdf. Accessed October 17, 2011.
11. Davidson J. Treatment of posttraumatic stress disorder with venlafaxine extended release: A 6-month randomized controlled trial. Arch Gen Psychiatry 2006;63:1158-1165.
12. Effexor XR® (venlafaxine HCl) Extended-Release Capsules, prescribing information. Mission, Kan: Pfizer; 2011. Available at: www.effexor.com. Accessed December 19, 2011.
13. Hoge CW. Interventions for war-related posttraumatic stress disorder: Meeting veterans where they are. JAMA 2011;306:549-551.
14. Mohamed S, Rosenheck RA. Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs. J Clin Psychiatry 2008;69: 959-965.
15. Schnurr PP, Friedman MJ, Engel CC, et al. Cognitive behavioral therapy for posttraumatic stress disorder in women: A randomized controlled trial. JAMA 2007;297:820-830.
16. Friedman MJ, Marmar CR, Baker DG, et al. Randomized, doubleblind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry 2007;68:711-720.
17. van der Kolk BA, Dreyfuss D, Michaels M, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:517-522.
18. Milliken CS, Auchterlonie JL, Hoge CW. Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war. JAMA 2007;298: 2141-2148.
19. American Psychiatric Association. APA practice guidelines: Treatment of patients with acute stress syndrome and posttraumatic stress disorder. March 2004. Available at: www.psychiatryonline.com/pracGuide/pracGuideChapToc_11.aspx. Accessed October 19, 2011.
20. Benedek DM, Friedman MJ, Zatzick D, Ursano RJ. Guideline Watch (2009): Treatment of patients with acute stress syndrome and posttraumatic stress disorder. Available at: www.psychiatryonline.com/content.aspx?aid=156498. Accessed October 19, 2011.
21. Brady KT, Sonne SC, Roberts JM. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry 1995;56:502-505.
22. Rothbaum BO, Ninan PT, Thomas L. Sertraline in the treatment of rape victims with posttraumatic stress disorder. J Trauma Stress 1996;9:865-871.
23. Greist J, Chouinard G, DuBoff E, et al. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995; 52:289-295.
24. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. JAMA 2000;283:1837-1844.
25. Davidson RT, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001; 58:485-492.
26. Zohar J, Amital D, Miodownik C, et al. Double-blind placebocontrolled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol 2002;22: 190-195.
27. Marshall RD, Beebe KL, Oldham M, Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. Am J Psychiatry 2001;158:1982-1988.
28. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebocontrolled, flexible-dosage trial. J Clin Psychiatry 2001;62:860-868.
29. Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in posttraumatic stress disorder: Randomised, double-blind study. Br J Psychiatry 1999;175:17-22.
30. Meltzer-Brody S, Connor KM, Churchill E, et al. Symptom- specific effects of fluoxetine in post-traumatic stress disorder. Int Clin Psychopharmacol 2000;15:227-231.
31. Martenyi F, Brown EB, Caldwell CD. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: Results of a fixed-dose, placebo-controlled study. J Clin Psychopharmacol 2007; 27:166-170.
32. Martenyi F, Brown EB, Zhang H, et al. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br J Psychiatry 2002;181:315-320.
33. Martenyi F, Brown EB, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry 2002;63:199-206.
34. Davidson J, Rothbaum BO, Tucker P, et al. Venlafaxine extended release in posttraumatic stress disorder: A sertraline- and placebocontrolled study. J Clin Psychopharmacol 2006;26:259-267.
35. Leslie DL, Mohamed S, Rosenheck RA. Off-label use of anti - psychotic medications in the Department of Veterans Affairs health care system. Psychiatr Serv 2009;60:1175-1181.
36. Seroquel® (quetiapine fumarate) Tablets, prescribing information. Wilmington, Del.: AstraZeneca; July 2011. Available at: www1.astrazeneca-us.com/pi/Seroquel.pdf. Accessed October 20, 2011.
37. Kozaric-Kovacic D, Pivac N. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features. Veterans Int J Neuropsychopharmacol 2007;10:253-261.
38. Ahearn EP, Mussey M, Johnson C, et al. Quetiapine as an adjunctive treatment for post-traumatic stress disorder: An 8-week open-label study. Int Clin Psychopharmacol 2006;21:29-33.
39. Sokolski KN, Denson TF, Lee RT, Reist C. Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder. Mil Med 2003;168:486-489.
40. Hamner MB, Deitsch SE, Brodrick PS, et al. Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol 2003;23:15-20.
41. Risperdal® (risperidone) Tablets, prescribing information. Titus - ville, N.J.: Janssen; August 2011. Available at: www.risperdal.com/prescribing.html. Accessed October 20, 2011.
42. Schotte A, Janssen PF, Gommeren W, et al. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 1996;124:57-73.
43. Hamner MB, Faldowski RA, Ulmer HG, et al. Adjunctive risperidone treatment in post-traumatic stress disorder: A preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol 2003;18:1-8.
44. Krystal JH, Rosenheck RA, Cramer JA, et al. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: A randomized trial. JAMA 2011; 306:493-502.
45. Zyprexa® (olanzapine) Tablets for Oral Use, prescribing information. Indianapolis, Ind.: Eli Lilly; June 2011. Available at: http://pi.lilly.com/us/zyprexa-pi.pdf. Accessed October 20, 2011.
46. Butterfield MI, Becker ME, Connor KM, et al. Olanzapine in the treatment of post-traumatic stress disorder: A pilot study. Int Clin Psychopharmacol 2001;16:197-203.
47. Petty F, Brannan S, Casada J, et al. Olanzapine treatment for posttraumatic stress disorder: An open-label study. Int Clin Psycho - pharmacol 2001;16:331-337.
48. Pivac N, Kozaric-Kovacic D, Muck-Seler D. Olanzapine versus fluphenazine in an open trial in patients with psychotic, combatrelated post-traumatic stress disorder. Psychopharmacology 2004; 175:451-456.
49. Jakovljevi M, Sagud M, Mihaljevi-Peles A. Olanzapine in the treatment- resistant, combat-related PTSD: A series of case reports. Acta Psychiatr Scand 2003;107:394-396.
50. Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRIresistant combat-related PTSD: A double-blind, placebo-controlled study. Am J Psychiatry 2002;159:1777-1779.
51. States JH, St. Dennis CD. Chronic sleep disruption and the reexperiencing cluster of posttraumatic stress disorder symptoms are improved by olanzapine: Brief review of the literature and a case-based series. Prim Care Companion J Clin Psychiatry 2003; 5:74-79.
52. The Management of Post-Traumatic Stress Working Group, 2010. VA/DoD Clinical Practice Guideline for the Management of Post- Traumatic Stress: Guideline Summary. Washington, D.C.: Department of Veterans Affairs and Department of Defense. Available at: www.healthquality.va.gov/ptsd/Mgmt_of_PTSD_final_92111.pdf. Accessed October 21, 2011.
53. Hamner M. Personal communication; October 7, 2011.